Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  News  >  Companies

News : Latest News
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors

Traffic Jam Events, LLC

share with twitter share with LinkedIn share with facebook
08/10/2020 | 05:59pm EDT
Traffic Jam Events, LLC
Last Updated: August 10, 2020
Case Status:
Pending
In the Matter of Traffic Jam Events, LLC, a limited liability company, and David J. Jeansonne II, individually and as an Officer of Traffic Jam Events, LLC.
FTC Matter/File Number:

X200041

Docket Number:

9395

Case Summary

The Federal Trade Commission took action to halt a scheme that allegedly deceived consumers with mailers supposedly directing them how to obtain federal COVID-19 stimulus benefits, which instead lured them to a used car sale.

The mailers sent by Traffic Jam Events, LLC and its owner, David J. Jeansonne II, were labeled 'IMPORTANT COVID-19 STIMULUS DOCUMENTS' and directed consumers to 'relief headquarters' to 'claim these stimulus incentives,' the FTC alleged in its lawsuit against the company and Jeansonne.

Case Timeline

Disclaimer

Federal Trade Commission published this content on 10 August 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 10 August 2020 21:58:06 UTC

share with twitter share with LinkedIn share with facebook
Latest news "Companies"
06:46aEpinephrine Autoinjector Market | Insights on the Crisis and the Roadmap to Recovery from COVID-19 Pandemic | Technavio
BU
06:46aSEATTLE GENETICS : and Astellas Announce PADCEV® (enfortumab vedotin-ejfv) Significantly Improved Overall Survival in Phase 3 Trial in Previously Treated Locally Advanced or Metastatic Urothelial Cancer
BU
06:46aMERCK : LYNPARZA® (olaparib) Improved Median Progression-Free Survival to Over Four and a Half Years Compared to 13.8 Months with Placebo for Patients with BRCA-Mutated Advanced Ovarian Cancer
BU
06:45aUnilever's Dutch shareholders vote on unification, HQ move
RE
06:45aKINGSWOOD : Consolidated Interim Report (for the six months ended 30 June 2020)
PU
06:45aANXIAN YUAN CHINA : Lapse of memorandum of understanding and use of proceeds of the rights issue
PU
06:45aCMBC CAPITAL : Next day disclosure return
PU
06:45aSINOPHARM : Announcement poll results of the extraordinary general meeting held on friday, 18 september 2020 election of the employee representative supervisors
PU
06:45aMortality in Portugal in the context of the COVID-19 pandemic - Weeks 1 to 35
PU
Latest news "Companies"